© 2000 American Heart Association, Inc.
Molecular Medicine |
Expression, Release, and Biological Activity of Parathyroid Hormone–Related Peptide From Coronary Endothelial Cells
From the Physiologisches Institut, Justus-Liebig-Universität Giessen, Giessen, Germany.
Correspondence to Dr Klaus-Dieter Schlüter, Physiologisches Institut, Aulweg 129, D-35392 Giessen, Germany. E-mail klaus-dieter.schlueter{at}physiologie.med.uni-giessen.de
Abstract—Ventricular cardiomyocytes have previously been identified as potential target cells for parathyroid hormone–related peptide (PTHrP). Synthetic PTHrP peptides exert a positive contractile effect. Because systemic PTHrP levels are normally negligible, this suggests that PTHrP is expressed in the ventricle and acts as a paracrine mediator. We investigated the ventricular expression of PTHrP and its expression in cultured cells isolated from the ventricle, studied the release of PTHrP from hearts and cultures, and investigated whether this authentic PTHrP mimics the biological effects previously described for synthetic PTHrP on ventricular cardiomyocytes. We found PTHrP expressed in ventricles of neonatal and adult rat hearts. In cells isolated from adult hearts, we found PTHrP expression exclusively in coronary endothelial cells but not in cardiomyocytes. The latter, however, are target cells for PTHrP. PTHrP was released from isolated perfused hearts during hypoxic perfusion and from cultured coronary endothelial cells under energy-depleting conditions. This PTHrP was biologically active; ie, it exerted a positive contractile and lusitropic effect on cardiomyocytes. Authentic PTHrP was glycosylated and showed a slightly higher potency than synthetic PTHrP. These results suggest that PTHrP is an endothelium-derived modulator of ventricular function.
Key Words: contractility • hypoxia • endothelial cells
This article has been cited by other articles:
 |
|
 |
|
  K.-D. Schluter, R. Schreckenberg, and S. Wenzel Stem cell mobilization versus stem cell homing: potential role for parathyroid hormone? Cardiovasc Res, March 1, 2008; 77(4): 612 - 613. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Halapas, P. Lembessis, I. Mourouzis, C. Pantos, D. V. Cokkinos, A. Sourla, and M. Koutsilieris Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model Exp Physiol, February 1, 2008; 93(2): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Meurrens, S. Ruf, G. Ross, R. Schleef, K. von Holt, and K.-D. Schluter Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats Cardiovasc Res, November 1, 2007; 76(2): 311 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ross and K.-D. Schluter Cardiac-specific effects of parathyroid hormone-related peptide: Modification by aging and hypertension Cardiovasc Res, May 1, 2005; 66(2): 334 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Andersson, E. Rydberg, and R. Willenheimer Primary hyperparathyroidism and heart disease -- a review Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Grohe, M. van Eickels, S. Wenzel, R. Meyer, H. Degenhardt, P. A Doevendans, M. P Heinemann, G. Ross, and K.-D. Schluter Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide Cardiovasc Res, February 1, 2004; 61(2): 307 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Funk, E. Migliati, G. Chen, H. Wei, J. Wilson, K. J. Downey, P. J. Mullarky, B. M. Coull, P. F. McDonagh, and L. S. Ritter Parathyroid hormone-related protein induction in focal stroke: a neuroprotective vascular peptide Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1021 - R1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Qian, M. C. Colbert, D. Witte, C.-Y. Kuan, E. Gruenstein, H. Osinska, B. Lanske, H. M. Kronenberg, and T. L. Clemens Midgestational Lethality in Mice Lacking the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Is Associated with Abrupt Cardiomyocyte Death Endocrinology, March 1, 2003; 144(3): 1053 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Schorr, G. Taimor, H. Degenhardt, K. Weber, and K.-D. Schluter Parathyroid Hormone-Related Peptide Is Induced by Stimulation of alpha 1A-Adrenoceptors and Improves Resistance against Apoptosis in Coronary Endothelial Cells Mol. Pharmacol., January 1, 2003; 63(1): 111 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jansen, P. Gres, C. Umschlag, F. R. Heinzel, H. Degenhardt, K.-D. Schluter, G. Heusch, and R. Schulz Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H49 - H55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Degenhardt, J. Jansen, R. Schulz, D. Sedding, R. Braun-Dullaeus, and K.-D. Schluter Mechanosensitive release of parathyroid hormone-related peptide from coronary endothelial cells Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1489 - H1496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-L. Laugwitz, H.-J. Weig, A. Moretti, E. Hoffmann, P. Ueblacker, I. Pragst, K. Rosport, A. Schomig, and M. Ungerer Gene Transfer of Heterologous G Protein-Coupled Receptors to Cardiomyocytes : Differential Effects on Contractility Circ. Res., April 13, 2001; 88(7): 688 - 695. [Abstract] [Full Text] [PDF]
|
|